Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioVigilant Systems is a leader in real-time microbial detection technology, specializing in environmental monitoring for the pharmaceutical and healthcare industries. The company's Instantaneous Microbial Detection (IMD) systems, including the IMD-A for air and IMD-W for water, utilize advanced optical spectroscopy to detect and count biological particles instantly. This technology enables manufacturers to monitor cleanroom environments and high-purity water systems without the delays associated with traditional culture-based methods. By providing immediate alerts to contamination, BioVigilant helps companies reduce risk, improve product quality, and optimize manufacturing efficiency. Since 2009, BioVigilant has operated as a subsidiary of Azbil Corporation, expanding its global reach in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioVigilant Systems.